Novavax (NASDAQ:NVAX) Shares Up 10.5% - Here's Why

Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up

Sanofi just handed Novavax a commercial lifeline for the fall vaccination season, and the stock is reacting in a way that leaves Moderna and BioNTech looking like bystanders. The real question is whether the royalty model powering this rally is as strong as the surge suggests.

Novavax (NASDAQ:NVAX) Shares Up 10.5% - Here's Why

Novavax (NASDAQ:NVAX) Stock Jumps 10.5% - Here's What Happened

Novavax (NASDAQ:NVAX) Shares Break Above Two Hundred Day Moving Average – Here’s Why

Novavax, Inc. (NASDAQ:NVAX – Get Free Report)’s share price passed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $9.04 and traded as high as $10.86. Novavax shares last traded at $10.46, with a volume of 4,023,008 shares changing hands. Wall Street Analysts Forecast Growth A number […]